Siemens Healthineers Appoints Li Hai as New Head of IVD Business in China

There is not much public information about Mr. Li Hai online. According to a 2022 report by China Business Journal, Mr. Li Hai was the head of Medtronic's Diabetes Business in Greater China; earlier online public information also shows that Mr. Li Hai served as the Director of Medtronic's Neuromodulation Business Department in Greater China.

Qichacha shows that Mr. Li Hai also serves as the General Manager of Medtronic Diabetes Technology (Chengdu) Co., Ltd., with the term of office from July 20, 2022, to February 11, 2026.

Hai Li will comprehensively oversee the development planning of the laboratory diagnostics business in China, drive business growth, and promote collaboration with the global team.

Hai Li has extensive business management experience in the healthcare industry, particularly excelling in business development and high-performance team building. Before joining Siemens Healthineers, Hai Li worked at Medtronic China for nearly 12 years. In the past five years, he served as the Head of MiniMed Greater China, overseeing the region's business management, leading the formulation of commercial strategies and daily operations, and continuously driving business growth with his team. MiniMed was originally a business unit under Medtronic and has recently completed an independent IPO in the United States.

Earlier, Hai Li also held multiple commercial management positions at B. Braun and Johnson & Johnson China, accumulating extensive experience in sales management, market strategy, and maintaining business partnerships, while successfully contributing to market expansion and performance improvement.

If there are any inaccuracies or infringement issues above, please feel free to contact the author for removal. Thank you!

---